Clozapine treatment causes oxidation of proteins involved in energy metabolism in lymphoblastoid cells

A possible mechanism for antipsychotic- induced metabolic alterations

Muhammad R. Baig, Erica Navaira, Michael A. Escamilla, Henriette Raventos, Consuelo Walss-Bass

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

There is increasing concern about the serious metabolic side effects and neurotoxicity caused by atypical (second-generation) antipsychotics. In a previous study by our group (Walss-Bass et al. Int J Neuropsychopharmacol 2008;11:1097-104), using a novel proteomic approach, we showed that clozapine treatment in SKNSH cells induces oxidation of proteins involved in energy metabolism, leading us to hypothesize that protein oxidation could be a mechanism by which atypical antipsychotics increase the risk for metabolic alterations. In this study, the same proteomic approach was used to identify specific proteins oxidized after clozapine treatment in lymphoblastoid cell lines from patients with schizophrenia and normal controls. Cells were treated with 0 and 20μM clozapine for 24 hours and protein extracts were labeled with 6-iodoacetamide fluorescein (6-IAF). The lack of incorporation of 6-IAF into the thiol group of cysteine residues is an indicator of protein oxidation. Labeled proteins were exposed to two dimensional electrophoresis, and differential protein labeling was assessed. Increased oxidation after clozapine treatment was observed in 9 protein spots (P<0.05). The following 7 proteins were identified by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry (HPLC-ESI-MS/MS) in those 9 spots: enolase, triosephosphate isomerase (TPI), glyceraldehyde-3-phosphate dehydrogenase (GAPD), Rho GDP dissociation inhibitor (GDI), cofilin, uridine monophosphate/ cytidine monophosphate (UMP-CMP) kinase, and translation elongation factor. Several of these proteins play important roles in energy metabolism and mitochondrial function. These results further support the hypothesis that oxidative stress may be a mechanism by which antipsychotics increase the risk of metabolic syndrome and diabetes.

Original languageEnglish (US)
Pages (from-to)325-333
Number of pages9
JournalJournal of Psychiatric Practice
Volume16
Issue number5
DOIs
StatePublished - Sep 2010

Fingerprint

Clozapine
Energy Metabolism
Antipsychotic Agents
Proteins
Therapeutics
Proteomics
Guanine Nucleotide Dissociation Inhibitors
High Pressure Liquid Chromatography
Actin Depolymerizing Factors
Triose-Phosphate Isomerase
Uridine Monophosphate
Peptide Elongation Factors
Glyceraldehyde-3-Phosphate Dehydrogenases
Electrospray Ionization Mass Spectrometry
Phosphopyruvate Hydratase
Tandem Mass Spectrometry
Sulfhydryl Compounds
Cysteine
Electrophoresis
Schizophrenia

Keywords

  • antipsychotics
  • clozapine
  • glucose metabolism
  • oxidative stress
  • proteomics
  • reactive oxygen species

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Clozapine treatment causes oxidation of proteins involved in energy metabolism in lymphoblastoid cells : A possible mechanism for antipsychotic- induced metabolic alterations. / Baig, Muhammad R.; Navaira, Erica; Escamilla, Michael A.; Raventos, Henriette; Walss-Bass, Consuelo.

In: Journal of Psychiatric Practice, Vol. 16, No. 5, 09.2010, p. 325-333.

Research output: Contribution to journalArticle

Baig, Muhammad R. ; Navaira, Erica ; Escamilla, Michael A. ; Raventos, Henriette ; Walss-Bass, Consuelo. / Clozapine treatment causes oxidation of proteins involved in energy metabolism in lymphoblastoid cells : A possible mechanism for antipsychotic- induced metabolic alterations. In: Journal of Psychiatric Practice. 2010 ; Vol. 16, No. 5. pp. 325-333.
@article{78d8763f8c274ab1b3aeb0bc7db22422,
title = "Clozapine treatment causes oxidation of proteins involved in energy metabolism in lymphoblastoid cells: A possible mechanism for antipsychotic- induced metabolic alterations",
abstract = "There is increasing concern about the serious metabolic side effects and neurotoxicity caused by atypical (second-generation) antipsychotics. In a previous study by our group (Walss-Bass et al. Int J Neuropsychopharmacol 2008;11:1097-104), using a novel proteomic approach, we showed that clozapine treatment in SKNSH cells induces oxidation of proteins involved in energy metabolism, leading us to hypothesize that protein oxidation could be a mechanism by which atypical antipsychotics increase the risk for metabolic alterations. In this study, the same proteomic approach was used to identify specific proteins oxidized after clozapine treatment in lymphoblastoid cell lines from patients with schizophrenia and normal controls. Cells were treated with 0 and 20μM clozapine for 24 hours and protein extracts were labeled with 6-iodoacetamide fluorescein (6-IAF). The lack of incorporation of 6-IAF into the thiol group of cysteine residues is an indicator of protein oxidation. Labeled proteins were exposed to two dimensional electrophoresis, and differential protein labeling was assessed. Increased oxidation after clozapine treatment was observed in 9 protein spots (P<0.05). The following 7 proteins were identified by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry (HPLC-ESI-MS/MS) in those 9 spots: enolase, triosephosphate isomerase (TPI), glyceraldehyde-3-phosphate dehydrogenase (GAPD), Rho GDP dissociation inhibitor (GDI), cofilin, uridine monophosphate/ cytidine monophosphate (UMP-CMP) kinase, and translation elongation factor. Several of these proteins play important roles in energy metabolism and mitochondrial function. These results further support the hypothesis that oxidative stress may be a mechanism by which antipsychotics increase the risk of metabolic syndrome and diabetes.",
keywords = "antipsychotics, clozapine, glucose metabolism, oxidative stress, proteomics, reactive oxygen species",
author = "Baig, {Muhammad R.} and Erica Navaira and Escamilla, {Michael A.} and Henriette Raventos and Consuelo Walss-Bass",
year = "2010",
month = "9",
doi = "10.1097/01.pra.0000388627.36781.6a",
language = "English (US)",
volume = "16",
pages = "325--333",
journal = "Journal of Psychiatric Practice",
issn = "1527-4160",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Clozapine treatment causes oxidation of proteins involved in energy metabolism in lymphoblastoid cells

T2 - A possible mechanism for antipsychotic- induced metabolic alterations

AU - Baig, Muhammad R.

AU - Navaira, Erica

AU - Escamilla, Michael A.

AU - Raventos, Henriette

AU - Walss-Bass, Consuelo

PY - 2010/9

Y1 - 2010/9

N2 - There is increasing concern about the serious metabolic side effects and neurotoxicity caused by atypical (second-generation) antipsychotics. In a previous study by our group (Walss-Bass et al. Int J Neuropsychopharmacol 2008;11:1097-104), using a novel proteomic approach, we showed that clozapine treatment in SKNSH cells induces oxidation of proteins involved in energy metabolism, leading us to hypothesize that protein oxidation could be a mechanism by which atypical antipsychotics increase the risk for metabolic alterations. In this study, the same proteomic approach was used to identify specific proteins oxidized after clozapine treatment in lymphoblastoid cell lines from patients with schizophrenia and normal controls. Cells were treated with 0 and 20μM clozapine for 24 hours and protein extracts were labeled with 6-iodoacetamide fluorescein (6-IAF). The lack of incorporation of 6-IAF into the thiol group of cysteine residues is an indicator of protein oxidation. Labeled proteins were exposed to two dimensional electrophoresis, and differential protein labeling was assessed. Increased oxidation after clozapine treatment was observed in 9 protein spots (P<0.05). The following 7 proteins were identified by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry (HPLC-ESI-MS/MS) in those 9 spots: enolase, triosephosphate isomerase (TPI), glyceraldehyde-3-phosphate dehydrogenase (GAPD), Rho GDP dissociation inhibitor (GDI), cofilin, uridine monophosphate/ cytidine monophosphate (UMP-CMP) kinase, and translation elongation factor. Several of these proteins play important roles in energy metabolism and mitochondrial function. These results further support the hypothesis that oxidative stress may be a mechanism by which antipsychotics increase the risk of metabolic syndrome and diabetes.

AB - There is increasing concern about the serious metabolic side effects and neurotoxicity caused by atypical (second-generation) antipsychotics. In a previous study by our group (Walss-Bass et al. Int J Neuropsychopharmacol 2008;11:1097-104), using a novel proteomic approach, we showed that clozapine treatment in SKNSH cells induces oxidation of proteins involved in energy metabolism, leading us to hypothesize that protein oxidation could be a mechanism by which atypical antipsychotics increase the risk for metabolic alterations. In this study, the same proteomic approach was used to identify specific proteins oxidized after clozapine treatment in lymphoblastoid cell lines from patients with schizophrenia and normal controls. Cells were treated with 0 and 20μM clozapine for 24 hours and protein extracts were labeled with 6-iodoacetamide fluorescein (6-IAF). The lack of incorporation of 6-IAF into the thiol group of cysteine residues is an indicator of protein oxidation. Labeled proteins were exposed to two dimensional electrophoresis, and differential protein labeling was assessed. Increased oxidation after clozapine treatment was observed in 9 protein spots (P<0.05). The following 7 proteins were identified by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry (HPLC-ESI-MS/MS) in those 9 spots: enolase, triosephosphate isomerase (TPI), glyceraldehyde-3-phosphate dehydrogenase (GAPD), Rho GDP dissociation inhibitor (GDI), cofilin, uridine monophosphate/ cytidine monophosphate (UMP-CMP) kinase, and translation elongation factor. Several of these proteins play important roles in energy metabolism and mitochondrial function. These results further support the hypothesis that oxidative stress may be a mechanism by which antipsychotics increase the risk of metabolic syndrome and diabetes.

KW - antipsychotics

KW - clozapine

KW - glucose metabolism

KW - oxidative stress

KW - proteomics

KW - reactive oxygen species

UR - http://www.scopus.com/inward/record.url?scp=77957580499&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957580499&partnerID=8YFLogxK

U2 - 10.1097/01.pra.0000388627.36781.6a

DO - 10.1097/01.pra.0000388627.36781.6a

M3 - Article

VL - 16

SP - 325

EP - 333

JO - Journal of Psychiatric Practice

JF - Journal of Psychiatric Practice

SN - 1527-4160

IS - 5

ER -